Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Breast Cancer Halted By Novartis Drug From Easter Island
Bloomberg
Monday, July 23, 2012 - 8:50am
tags:
Novartis, Afinitor, breast cancer
Elder Pharma forms new dedicated division to strengthen product reach and elevate brands
Equity Bulls
Sunday, July 22, 2012 - 8:53am
tags:
Elder Pharmaceuticals
Pfizer stops Teva selling generic Lyrica
Globes, Israel
Sunday, July 22, 2012 - 8:42am
tags:
Pfizer, Lyrica, generics
Double Disappointment! Has This Pharma Lost Its Touch?
Motley Fool
Sunday, July 22, 2012 - 8:35am
tags:
Bristol-Myers Squibb
Has This Obesity-Drug Maker Gained Too Much Weight?
Motley Fool
Sunday, July 22, 2012 - 8:33am
tags:
Vivus, Qsymia, weight loss, obesity
Amicus Therapeutics' CEO Hosts GSK Expanded Fabry Collaboration Call (Transcript)
Seeking Alpha
Sunday, July 22, 2012 - 8:32am
tags:
GSK, Amicus Therapeutics
Vivus Tips the Second Scale of Hope for Slimming Obesity
Wall St Cheat Street
Sunday, July 22, 2012 - 8:30am
tags:
Vivus, Qsymia, obesity, weight loss
Biotech Industry Showing Impressive Growth -- Galena Biopharma and Synta Pharmaceuticals Soaring
Business Review USA
Saturday, July 21, 2012 - 12:12pm
tags:
Galena Biopharma, Synta Pharmaceuticals
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe
Enhanced Online News
Saturday, July 21, 2012 - 12:11pm
tags:
Adcetris, Takeda, Millennium
Taro board rejects Sun Pharma offer for total control
Hindu BusinessLine, India
Saturday, July 21, 2012 - 12:07pm
tags:
Taro, Sun Pharma, M&A
Sunshine Biopharma signs Adva-27a manufacturing contract with Beta Pharma
Process and Production
Saturday, July 21, 2012 - 12:04pm
tags:
Sunshine Biopharma, breast cancer, Beta Pharma, Adva-27a, small cell lung cancer
EnVivo Pharma reports positive phase II b trial results from EVP-6124 in Alzheimer’s disease
Pharmabiz
Saturday, July 21, 2012 - 12:02pm
tags:
EnVivo, EVP-6124, Alzheimer's disease
Pfizer Must Pay $10.4 Million In Prempro Lawsuit, Court Rules
Bloomberg
Saturday, July 21, 2012 - 11:59am
tags:
Pfizer, Prempro, lawsuits
Personalized Medicine Plus Diagnostics Equals Profits for Investors
Motley Fool
Saturday, July 21, 2012 - 11:58am
tags:
Therascreen, Qiagen, Eli Lilly, Bristol-Myers Squibb, Agilent
Synergy Pharmaceuticals Signs Definitive Agreement to Acquire Callisto Pharmaceuticals
Yahoo/Globe NewsWire
Saturday, July 21, 2012 - 11:55am
tags:
Callisto Pharmaceuticals, Synergy Pharmaceuticals
J&J Appeals $1.2 Billion Arkansas Risperdal Ruling
Bloomberg
Saturday, July 21, 2012 - 11:53am
tags:
JNJ, Risperdal, lawsuits
Better Buy: J&J or Abbott?
Motley Fool
Saturday, July 21, 2012 - 11:52am
tags:
JNJ, Abbott Laboratories
UPDATE 2-US FDA approves Novartis drug Afinitor for breast cancer
Reuters
Saturday, July 21, 2012 - 11:51am
tags:
Novartis, Afinitor, breast cancer
Bristol-Myers Squibb Second Quarter Earnings Sneak Peek
Wall St Cheat Street
Saturday, July 21, 2012 - 11:50am
tags:
Bristol-Myers Squibb, earnings
One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers
Seeking Alpha
Saturday, July 21, 2012 - 11:48am
tags:
StemCells, Astex, Pluristem Therapeutics, ONYX Pharmaceuticals, Vivus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.